BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

964 related articles for article (PubMed ID: 26079477)

  • 21. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2010; 30(7):1002-11. PubMed ID: 20616679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RELATIONSHIP BETWEEN RETINAL THICKNESS AND VISUAL ACUITY IN EYES WITH RETINAL VEIN OCCLUSION TREATED WITH DEXAMETHASONE IMPLANT.
    Danis RP; Sadda S; Jiao J; Li XY; Whitcup SM
    Retina; 2016 Jun; 36(6):1170-6. PubMed ID: 26655606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
    Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker.
    Furino C; Boscia F; Recchimurzo N; Sborgia C; Alessio G
    Retina; 2014 Aug; 34(8):1612-6. PubMed ID: 24752008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective, controlled observational case study of patients with central retinal vein occlusion and initially low visual acuity treated with an intravitreal dexamethasone implant.
    Winterhalter S; Vom Brocke GA; Pilger D; Eckert A; Schlomberg J; Rübsam A; Klamann MK; Gundlach E; Dietrich-Ntoukas T; Joussen AM
    BMC Ophthalmol; 2016 Oct; 16(1):187. PubMed ID: 27784291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion.
    Kuppermann BD; Haller JA; Bandello F; Loewenstein A; Jiao J; Li XY; Whitcup SM
    Retina; 2014 Sep; 34(9):1743-9. PubMed ID: 24830824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
    Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study.
    Iglicki M; Busch C; Zur D; Okada M; Mariussi M; Chhablani JK; Cebeci Z; Fraser-Bell S; Chaikitmongkol V; Couturier A; Giancipoli E; Lupidi M; Rodríguez-Valdés PJ; Rehak M; Fung AT; Goldstein M; Loewenstein A
    Retina; 2019 Jan; 39(1):44-51. PubMed ID: 29697589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
    Ferrini W; Ambresin A
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COMBINED VITRECTOMY WITH INTRAVITREAL DEXAMETHASONE IMPLANT FOR REFRACTORY MACULAR EDEMA SECONDARY TO DIABETIC RETINOPATHY, RETINAL VEIN OCCLUSION, AND NONINFECTIOUS POSTERIOR UVEITIS.
    Pang JP; Son G; Yoon YH; Kim JG; Lee JY
    Retina; 2020 Jan; 40(1):56-65. PubMed ID: 30312262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
    Khurana RN; Porco TC
    Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.
    Gu X; Yu X; Song S; Dai H
    Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema.
    Guigou S; Pommier S; Meyer F; Hajjar C; Merite PY; Parrat E; Rouhette H; Rebollo O; Matonti F
    Ophthalmologica; 2015; 233(3-4):169-75. PubMed ID: 25924737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].
    Brunner M; Haueter I; Valmaggia C
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):396-400. PubMed ID: 23629790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in macular function after ozurdex for retinal vein occlusion.
    Querques G; Cascavilla ML; Cavallero E; Triolo G; Querques L; Lattanzio R; Cicinelli MV; Preziosa C; Borrelli E; Bandello F
    Optom Vis Sci; 2014 Jul; 91(7):760-8. PubMed ID: 24927143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Age on Dexamethasone Intravitreal Implant (Ozurdex®) Response in Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Altunel O; Göktaş A; Duru N; Özköse A; Arifoğlu HB; Ataş M
    Semin Ophthalmol; 2018; 33(2):179-184. PubMed ID: 27599562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.